Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GLUE

Monte Rosa Therapeutics Inc

May 29 • 04:00PM ET

19.71

+0.32 1.65 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NRIX KYMR RCUS TNGX CGON NUVL RYTM BMRN INCY KRYS

| Held by: VTI XBI AVUV IWM VXF IWN FYC IBB BSVO VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.63	Insider Own	31.47%	Shs Outstand	84.32M	Perf Week	4.40%
Market Cap	1.67B	Forward P/E	-	EPS next Y	-1.84	Insider Trans	-0.37%	Shs Float	57.89M	Perf Month	5.29%
Enterprise Value	1.04B	PEG	-	EPS next Q	-0.38	Inst Own	82.78%	Short Float	25.85%	Perf Quarter	11.04%
Income	-130.01M	P/S	38.77	EPS this Y	-260.08%	Inst Trans	35.93%	Short Ratio	15.18	Perf Half Y	23.03%
Sales	42.95M	P/B	3.18	EPS next Y	-10.86%	ROA	-23.02%	Short Interest	14.96M	Perf YTD	25.70%
Book/sh	6.19	P/C	2.50	EPS next 5Y	-	ROE	-32.62%	52W High	25.77 -23.52%	Perf Year	365.96%
Cash/sh	7.89	P/FCF	-	EPS past 3/5Y	41.29% 10.62%	ROIC	-23.36%	52W Low	3.90 405.38%	Perf 3Y	217.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	80.59%	Volatility	5.21% 5.37%	Perf 5Y	-
Dividend TTM	-	EV/Sales	24.17	EPS Y/Y TTM	-2335.85%	Oper. Margin	-345.21%	ATR (14)	1.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.54	Sales Y/Y TTM	-73.07%	Profit Margin	-302.69%	RSI (14)	57.33	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.54	EPS Q/Q	-178.84%	SMA20	3.23%	Beta	1.60	Target Price	32.33
Payout	-	Debt/Eq	0.07	Sales Q/Q	-95.04%	SMA50	7.99%	Rel Volume	1.15	Prev Close	19.39
Employees	150	LT Debt/Eq	0.07	Earnings	May 07 BMO	SMA200	32.01%	Avg Volume	985.39K	Price	19.71
IPO	Jun 24, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.91% -61.88%	Trades		Volume	1,133,072	Change	1.65%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)